Proteases Market size is expected to see notable proceeds between 2021 to 2027 on account of increasing application scope across diverse industries and higher advancements in protein engineering technology. The growing prevalence of diseases along with the rising focus towards enhanced digestibility and decreased production costs of food products will significantly drive the market growth.
Proteases, which are derived from plants, animals, and microorganisms, are mainly enzymes used for protein degradation across an extensive set of industries to break the peptide bonds of proteins.
Microbial protease market is likely to gain traction on account of its commercial viability and assistance in yield improvement. The limitations of plant and animal sources is another promising factor influencing the proteases market outlook.
Based on products, alkaline is anticipated to generate significant revenues with wide penetration across the textile manufacturing, detergent, as well as the paper & pulp sector owing to its high-temperature functional properties.
Food & beverage application will fuel the proteases industry share due to growing adoption for beef tenderization and to offer better functional properties in seafood products. The rise in levels of consumer health consciousness has made way for the imposition of favorable regulations for organic farming. The increasing use of alkaline proteases to offer high nutritional value will also add positive impetus to the proteases market expansion by 2027.
Detergent applications will record significant proteases demand with consistent developments in producing high performing products to meet the changing cleaning patterns of consumers. To state an instance, DuPont Nutrition & Biosciences, in April 2019, launched a novel portfolio of biobased enzymes, OPTIMASE, for liquid detergents in medical instrument cleaning applications.
On the basis of production technique, market will garner substantial benefits from fermentation segment. The production using this technique is cost effective as well as time saving, favoring the proteases market growth.
Regionally, Asia Pacific will record substantial consumption of proteases from 2021 to 2027 on account of the immense business and application scope, considering the economic and performance benefits of the product. Expanding urbanization and mounting demand across the processed food, animal feed, soap & detergent, and pharmaceutical applications will further fuel the regional growth.
Novel product launches, partnerships, mergers and acquisitions, portfolio and capacity expansions along with investment strategies, are among the key initiatives employed by major proteases providers in the industry to gain competitive benefits and enhanced global footprint.
For instance, in March 2021, Novozymes launched Formea Prime, a new protease enzyme, to expand its Formea portfolio of protein drink ingredients and to help beverage formulators tackle the challenges of using whey protein hydrolysates.
Likewise, Amunix Pharmaceuticals, Inc., in March 2021, secured $117 million in a Series B financing round to fund progressions into the clinic of AMX-818, a masked and protease-activated T cell engager that targets HER2-expressing solid tumors.
Some of the leading participants include Advanced Enzyme Technologies, Chr. Hansen, Amano Enzyme, Specialty Enzymes and Biotechnologies (Advanced Enzymes USA), Dyadic International, Associated British Food (Wittington Investments), Biocatalysts (BRAIN AG), DuPont and DSM.
The current COVID-19 crisis triggered a groundbreaking effect on the global economy given the imposition of lockdown and social distancing policies in various countries, whilst significantly meddling with the consumer lifestyle patterns. Apart from bringing the closure of industrial operations and numerous facilities, it also caused varying levels of anxiety, concerns, and fear pertaining to the effective treatment of the SARS-CoV-2 infection.
However, the pandemic has proved as a big booster to the proteases industry with emerging applications in the pharma sector. The increasing quest for effective medication to counter the virus has led to higher adoption of viral or host proteases to mediate viral entry and the pathogenesis of the viral infection. As exogenous and endogenous agents targeting proteases are found to be effective towards various viral infections, including the HIV and influenza virus, researchers have suggested that protease inhibitors can show promising antiviral treatment for COVID-19.